recombinant human lysosomal acid lipase (Shire Human Genetic Therapies)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namerecombinant human lysosomal acid lipase (Shire Human Genetic Therapies)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionLipase stimulants
TargetsLipase
Therapy Area/IndicationsLysosomal acid lipase deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesShire Human Genetic Therapies, Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire Human Genetic Therapies, Inc
Active IndicationsN/A
Inactive IndicationsLysosomal acid lipase deficiency

Other Information

ATC CodeN/A
Related LinksN/A